Preliminary Study of Transcranial Magnetic Stimulation for Stroke Rehabilitation
NCT ID: NCT00050128
Last Updated: 2017-07-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
15 participants
INTERVENTIONAL
2002-11-18
2007-10-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Stroke patients with residual arm function and no history of seizures may be eligible for this study. The stroke must have occurred at least 6 months before entry into the study and must have affected only one side of the brain.
For the TMS procedure, subjects are seated in a comfortable chair with their hands placed on a pillow on their lap. An insulated wire coil is placed on the scalp. A brief electrical current is passed through the coil, creating a magnetic pulse that stimulates the outer part of the brain, called the cortex. This may cause muscle, hand or arm twitching if the coil is near the part of the brain that controls movement, or it may affect movements or reflexes. Subjects are asked to make movements, do simple tasks, or tense muscles. Metal electrodes are taped to the skin over the muscle for computer recording of the electrical activity of the hand and arm muscles activated by the stimulation. The testing lasts 2-3 hours.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of rTMS and tDCS on Motor Function in Stroke
NCT01574989
Effect of Repetitive Transcranial Magnetic Stimulation on Neurological Recovery in Patients With Ischaemic Stroke
NCT06415734
Repetitive Transcranial Magnetic Stimulation Use in Acute Stroke
NCT01922986
Primed vs. Unprimed rTMS in Chronic Stroke
NCT01757821
Using Repetitive Transcranial Magnetic Stimulation (rTMS) in the Rehabilitation of Chronic Spatial Neglect After Stroke
NCT01000103
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A promising technique is repetitive transcranial magnetic stimulation (rTMS) that, so far, has produced some effects on motor function on other movement disorders like Parkinson's disease (PD). We hypothesize that rTMS will have a beneficial effect on motor function in chronic stroke patients. Specifically, we propose to look at the effect of 20 and 25 Hz stimulation since these types of stimulation have been shown to increase the excitability of the cerebral cortex.
The purpose of this protocol is to investigate the effect of repetitive transcranial stimulation (rTMS) on the motor cortex of chronic stroke patients and motor function. Four different stimulation parameters within the limits of current safety guidelines will be used. We plan to determine; 1) which rTMS stimulation parameters induce more cortex excitability, 2) whether there is any improvement of hand motor function after rTMS, and 3) if the applied stimulation parameters are safe in chronic stroke patients. The optimal parameters will be subsequently proposed for use in an experimental protocol for rehabilitation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
TREATMENT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
rTMS, Magstim
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
They should be able to perform the pinch task.
Their gender or ethnic origin will not provide bias for inclusion to the study.
All subjects will sign an informed consent prior to participation in the trial.
Exclusion Criteria
Additional exclusion include patients with:
History of more than one stroke;
Large cortical, cerebellar, or brainstem lesions;
An inability to extend metacarpophalangeal (MP) joints at least 10-20 degrees;
Substantially recovered motor function;
Severe depression;
Poor motivational capacity, or severe language disturbances (particularly of receptive nature);
Severe spasticity/pain;
Bilateral motor problems;
Serious cognitive deficits (defined as equivalent to a mini-mental state exam score of 20 or less);
Uncontrolled medical problems, such as: cardiopulmonary disease, severe rheumatoid arthritis, active joint deformity of arthritic origin, active cancer, or renal disease;
Uncontrollable issues due to natural aging;
History of seizure(s).
All patients will underfo electroencephalogram (EEG) examination prior to rTMS experiment as a part of the screening procedure.
Patients without any history of seizures, but with any sign of increased cerebral activity in the EEG will be excluded.
Women who are pregnant may not participate and women who are of childbearing years must be post-menopausal, sterile, or practicing adequate birth control.
Children will be excluded.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
The uses of epidemiology in the study of the elderly. Report of a WHO Scientific Group on the Epidemiology of Aging. World Health Organ Tech Rep Ser. 1984;706:1-84. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
03-N-0049
Identifier Type: -
Identifier Source: secondary_id
030049
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.